Perindopril Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2 mg, 4 mg, 8 mg, and 16 mg
Reference Brands: Coversyl, Aceon(EU)
Category:
Heart Disorder
Perindopril is an ACE inhibitor that blocks the conversion of angiotensin I to angiotensin II, causing vasodilation. It lowers blood pressure, reduces heart workload, and prevents strokes and heart attacks. Benefits include improved cardiovascular health, symptom relief, and long-term protection against heart failure and related complications.
Perindopril tablet is available in Tablet
and strengths such as 2 mg, 4 mg, 8 mg, and 16 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Perindopril tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Perindopril tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Perindopril tablets, marketed as Coversyl and generic in the EU and US, are approved for hypertension and heart failure management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability of perindopril tablets, helping improve cardiovascular health outcomes worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing